臨試
https://clinicaltrials.gov/ct2/show/NCT03715114
https://ichgcp.net/clinical-trials-registry/NCT02293915
另幾篇報道
https://www.thepharmaletter.com/article/alzheimer-s-treatment-from-china-meets-phase-iii-goal
那個藥
”GV-971 is a novel, marine-derived oligosaccharide, which has multi targeting mechanisms including inhibition of amyloid-β fibril formation, neuroinflammation, and recondition of dysbiosis of gut microbiota",
長期效果及副作用有待進一步評估